IL1B and cardiac hypertrophy: Diabetes aggravated adverse cardiac remodeling, increased the mortality rate, cardiac hypertrophy, the fibrotic area, and enhanced IL-1β, IL-6, TNF-α, and IL-18 expression in myocardial tissue.